Wei Li1,
De-Yuan Li2 
,
Hai-Dong Wang2,
Zhe-Jun Zheng2,
Jie Hu2,
Zong-Zhe Li2
For correspondence:- De-Yuan Li Email: deyuanli3265@gmail.com Tel:00862783810935
Received: 24 November 2014 Accepted: 26 February 2015 Published: 31 March 2015
Citation: Li W, Li D, Wang H, Zheng Z, Hu J, Li Z. Juglans regia hexane extract exerts antitumor effect, apoptosis induction and cell circle arrest in prostate cancer cells in vitro. Trop J Pharm Res 2015; 14(3):399-405 doi: 10.4314/tjpr.v14i3.7
© 2015 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..
Purpose: To elucidate the anticancer activity of Juglans regia leaf extract and its effect on cell cycle analysis, apoptosis and cancer cell morphology.
Methods: Hexane extract of the leaves of Juglans regia was prepared by hot extraction. The anticancer activity of Juglans regia extract against human prostate cancer (PC3) cells was evaluated by MTT assay. Flow cytometry, using propidium iodide as a staining agent, was used to study the effect of the extract on cell cycle phase distribution. Apoptosis induced by the extract was evaluated by Annexin V binding assay using flow cytometer. Alterations in cell morphology following apoptosis were studied by inverted phase contrast microscope.
Results: The extract of Juglans regia exhibited a potent and dose-dependent anti-proliferative activity against human prostate cancer cells in vitro. The extract also induced significant apoptosis in these PC3 cancer cells as revealed by annexin V binding assay as well as inverted phase contrast microscopy. It triggered a significant formation of apoptotic bodies after treatment with varying concentrations of the extract. Within 48 h of incubation, approximately 9.5, 15.5 and 26.3 % of the cells underwent early apoptosis after treatment with 5, 50 and 100 µg/mL of the extract, respectively. Similarly, 5.2, 11.2 and 18.9 % of the cells underwent late apoptosis after treatment with 5, 50 and 100 µg/mL of the extract, respectively. Treatment with different concentrations of the extract for 48 h induced an increase in the population of cells in the sub-G1 phase and a slight decrease in the G2/M phase.
Conclusion: The hexane extract of Juglans regia inhibits growth of human prostate cancer cells by inducing apoptosis with concomitant alterations in cell cycle phase distribution.
Archives
News Updates
Fulltext in PDF